{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:25:54Z","timestamp":1790637954068,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Studies of antipsychotic medication, which are increasingly prescribed for a broad range of problems and circumstances, rarely ask the people who take them to describe their experiences with the drugs. In this study, 650 people, from 29 countries, responded, in an online survey, to \u201cOverall in my life antipsychotic medications have been _____?\u201d and \u201cIs there anything else you would like to say, or emphasise, about your experiences with antipsychotic drugs?\u201d Of the total participants, 14.3% were categorized as reporting purely positive experiences, 27.9% had mixed experiences, and 57.7% reported only negative ones. Negative experiences were positively correlated with age. Thematic analysis identified 749 negative, 180 positive, and 53 mixed statements. The 2 positive themes were \u201csymptom reduction\u201d (14) and \u201csleep\u201d (14), with the majority (153) unspecified. The 4 negative themes (besides \u201cunspecified\u201d\u2014191) were: \u201cadverse effects\u201d (316), \u201cinteractions with prescriber\u201d (169), \u201cwithdrawal\/difficult to get off them\u201d (62), and \u201cineffective\u201d (11). The adverse effects included: weight gain, emotional numbing, cognitive dysfunction, sedation, akathisia, effects on relationships, and suicidality. \u201cInteractions with prescriber\u201d included lack of information about withdrawal effects, support, or discussion of alternatives. The only mixed theme was \u201cshort-term good, long-term bad\u201d (28). Open questions can add to findings from methodologies focused on symptom reduction. Clinicians should pay more attention to the need for respectful and collaborative patient-prescriber relationships. At the point of prescription, this must include providing the full range of information about antipsychotics, including potential benefits and harms, difficulties withdrawing, and information on alternatives treatments such as psychological therapies.<\/jats:p>","DOI":"10.1093\/schbul\/sbaa002","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T20:10:28Z","timestamp":1578427828000},"page":"896-904","source":"Crossref","is-referenced-by-count":39,"title":["Using Open Questions to Understand 650 People\u2019s Experiences With Antipsychotic Drugs"],"prefix":"10.1093","volume":"46","author":[{"given":"John","family":"Read","sequence":"first","affiliation":[{"name":"Department of Psychology, University of East London \u2013 Stratford Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Sacia","sequence":"first","affiliation":[{"name":"Department of Psychology, University of East London \u2013 Stratford Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"2020070810443241600_CIT0001","volume-title":"Practice Guidelines for the Treatment of Patients With Schizophrenia","author":"American Psychiatric Association.","year":"2010"},{"key":"2020070810443241600_CIT0002","volume-title":"Psychosis and Schizophrenia in Adults. Quality Standard","author":"National Institute for Health and Care Excellence.","year":"2015"},{"key":"2020070810443241600_CIT0003","first-page":"105","article-title":"Antipsychotic drugs","volume-title":"Models of Madness: Psychological, Social and Biological Approaches to Psychosis","author":"Hutton","year":"2013"},{"key":"2020070810443241600_CIT0004","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006374.pub2","article-title":"Antipsychotic medication for early episode schizophrenia","author":"Bola","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2020070810443241600_CIT0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17522430802610008","article-title":"Psychosocial treatment, antipsychotic postponement, and low-dose medication strategies in first episode psychosis","volume":"1","author":"Bola","year":"2009","journal-title":"Psychosis"},{"key":"2020070810443241600_CIT0006","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2017.06.069","article-title":"A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia","volume":"256","author":"Harrow","year":"2017","journal-title":"Psychiatry Res"},{"issue":"10","key":"2020070810443241600_CIT0007","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1017\/S0033291716000775","article-title":"Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study","volume":"46","author":"Jung","year":"2016","journal-title":"Psychol Med"},{"key":"2020070810443241600_CIT0008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eurpsy.2011.06.009","article-title":"Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication: a 10-year follow-up of the Northern Finland 1966 Birth Cohort study","volume":"28","author":"Moilanen","year":"2013","journal-title":"Europ Psychiatry"},{"issue":"10","key":"2020070810443241600_CIT0009","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2017.16121358","article-title":"Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, bayesian meta-analysis, and meta-regression of efficacy predictors","volume":"174","author":"Leucht","year":"2017","journal-title":"Am J Psychiatry"},{"key":"2020070810443241600_CIT0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1192\/bjp.bp.108.050088","article-title":"Extrapyramidal side-effects of antipsychotics in a randomised trial","volume":"193","author":"Miller","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"1","key":"2020070810443241600_CIT0011","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/WNF.0000000000000117","article-title":"Assessing and reporting the adverse effects of antipsychotic medication: a systematic review of clinical studies, and prospective, retrospective, and cross-sectional research","volume":"39","author":"Longden","year":"2016","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"2020070810443241600_CIT0012","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"2020070810443241600_CIT0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.05.018","article-title":"Influence of antipsychotics on mortality in schizophrenia: systematic review","volume":"113","author":"Weinmann","year":"2009","journal-title":"Schizophr Res"},{"key":"2020070810443241600_CIT0014","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/17522430903501999","article-title":"Antipsychotic medication, mortality and neurodegeneration","volume":"2","author":"Weinmann","year":"2010","journal-title":"Psychosis"},{"issue":"5","key":"2020070810443241600_CIT0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1600-0447.1996.tb10666.x","article-title":"Schizophrenic patients\u2019 experiences of neuroleptic medication: a Q-methodological investigation","volume":"93","author":"Day","year":"1996","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"2020070810443241600_CIT0016","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0447.1998.tb09969.x","article-title":"A comparison of patients\u2019 and prescribers\u2019 beliefs about neuroleptic side-effects: prevalence, distress and causation","volume":"97","author":"Day","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"2020070810443241600_CIT0017","article-title":"Antipsychotic treatment \u2013 a systematic literature review and meta-analysis of qualitative studies","author":"Bjornestad","journal-title":"J Ment Health"},{"issue":"1","key":"2020070810443241600_CIT0018","first-page":"61","article-title":"A qualitative study of antipsychotic medication experiences of youth","volume":"24","author":"Murphy","year":"2015","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"3","key":"2020070810443241600_CIT0019","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/inm.12110","article-title":"Living with antipsychotic medication side-effects: the experience of Australian mental health consumers","volume":"24","author":"Morrison","year":"2015","journal-title":"Int J Ment Health Nurs"},{"issue":"2","key":"2020070810443241600_CIT0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0447.2009.01356.x","article-title":"The subjective experience of taking antipsychotic medication: a content analysis of Internet data","volume":"120","author":"Moncrieff","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"2020070810443241600_CIT0021","first-page":"1","article-title":"Personal accounts of discontinuing neuroleptic medication for psychosis","volume":"26","author":"Geyt","year":"2016","journal-title":"Qual Health Res"},{"issue":"7","key":"2020070810443241600_CIT0022","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00127-018-1518-x","article-title":"Attempting to stop antipsychotic medication: success, supports, and efforts to cope","volume":"53","author":"Larsen-Barr","year":"2018","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2020070810443241600_CIT0023","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.psychres.2018.10.001","article-title":"Attempting to discontinue antipsychotic medication: withdrawal methods, relapse and success","volume":"270","author":"Larsen-Barr","year":"2018","journal-title":"Psychiatry Res"},{"key":"2020070810443241600_CIT0024","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1037\/prj0000001","article-title":"\u2018All roads lead to medication?\u2019 Qualitative responses from an Australian first-person survey of antipsychotic discontinuation","volume":"36","author":"Salomon","year":"2013","journal-title":"Psychiatrc Rehabil J"},{"issue":"7","key":"2020070810443241600_CIT0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archpsyc.62.7.717","article-title":"Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals","volume":"62","author":"Day","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"2020070810443241600_CIT0026","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/09638237.2017.1370637","article-title":"The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample","volume":"27","author":"Morant","year":"2018","journal-title":"J Ment Health"},{"issue":"5","key":"2020070810443241600_CIT0027","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/hex.12392","article-title":"Shared decision making for psychiatric medication management: beyond the micro-social","volume":"19","author":"Morant","year":"2016","journal-title":"Health Expect"},{"issue":"1","key":"2020070810443241600_CIT0028","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2648.2005.03561.x","article-title":"A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication","volume":"52","author":"Gray","year":"2005","journal-title":"J Adv Nurs"},{"issue":"3","key":"2020070810443241600_CIT0029","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1574886314666190301152734","article-title":"Positive and negative effects of antipsychotic medication: an international online survey of 832 recipients","volume":"14","author":"Read","year":"2019","journal-title":"Curr Drug Saf"},{"issue":"3","key":"2020070810443241600_CIT0030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1574886313666180605095130","article-title":"Adverse effects of antidepressants reported by a large international cohort: emotional blunting, suicidality, and withdrawal effects","volume":"13","author":"Read","year":"2018","journal-title":"Curr Drug Saf"},{"key":"2020070810443241600_CIT0031","volume-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"1981"},{"key":"2020070810443241600_CIT0032","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"13","key":"2020070810443241600_CIT0033","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1017\/S0033291717000903","article-title":"What side effects are problematic for patients prescribed antipsychotic medication? the maudsley side effects (MSE) measure for antipsychotic medication","volume":"47","author":"Wykes","year":"2017","journal-title":"Psychol Med"},{"key":"2020070810443241600_CIT0034","author":"DGPPN","year":"2019"},{"key":"2020070810443241600_CIT0035","first-page":"109","article-title":"Patients\u2019 experiences of consultations for depression and predictors of adherence to antidepressants","volume":"12","author":"Byng","year":"2007","journal-title":"Primary Care Comm Psychiatry"},{"issue":"6","key":"2020070810443241600_CIT0036","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/inm.12488","article-title":"How many of 1829 antidepressant users report withdrawal effects or addiction?","volume":"27","author":"Read","year":"2018","journal-title":"Int J Ment Health Nurs"},{"key":"2020070810443241600_CIT0037","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.psychres.2017.07.003","article-title":"The interpersonal adverse effects reported by 1008 users of antidepressants; and the incremental impact of polypharmacy","volume":"256","author":"Read","year":"2017","journal-title":"Psychiatry Res"},{"issue":"6","key":"2020070810443241600_CIT0038","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0277-9536(99)00376-7","article-title":"Doctor-patient communication about drugs: the evidence for shared decision making","volume":"50","author":"Stevenson","year":"2000","journal-title":"Soc Sci Med"},{"issue":"6","key":"2020070810443241600_CIT0039","doi-asserted-by":"crossref","first-page":"e0218711","DOI":"10.1371\/journal.pone.0218711","article-title":"Mental health professionals\u2019 views and experiences of antipsychotic reduction and discontinuation","volume":"14","author":"Cooper","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"2020070810443241600_CIT0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/M13-2796","article-title":"Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study","volume":"161","author":"Hwang","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"2020070810443241600_CIT0041","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/schbul\/sbt043","article-title":"Treating older adults with schizophrenia: challenges and opportunities","volume":"39","author":"Jeste","year":"2013","journal-title":"Schizophr Bull"},{"issue":"10","key":"2020070810443241600_CIT0042","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.4088\/JCP.15m09863","article-title":"Antipsychotic treatment of adults in the United States","volume":"76","author":"Olfson","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"2020070810443241600_CIT0043","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2082","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995\u20132008","volume":"20","author":"Alexander","year":"2011","journal-title":"Phamacoepidemiol Drug Saf"},{"issue":"5","key":"2020070810443241600_CIT0044","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.nmd.0000253783.32338.6e","article-title":"Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study","volume":"195","author":"Harrow","year":"2007","journal-title":"J Nerv Ment Dis"},{"issue":"9","key":"2020070810443241600_CIT0045","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamapsychiatry.2013.19","article-title":"Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction\/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial","volume":"70","author":"Wunderink","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"2020070810443241600_CIT0046","first-page":"182","article-title":"Psychosocial interventions for people with psychosis or schizophrenia on minimal or no antipsychotic medication: a systematic review","volume":"30","author":"Cooper","year":"2019","journal-title":"Schizophr Res"},{"issue":"1","key":"2020070810443241600_CIT0047","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbm047","article-title":"A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia","volume":"34","author":"Calton","year":"2008","journal-title":"Schizophr Bull"},{"key":"2020070810443241600_CIT0048","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17522439.2011.601750","article-title":"The comprehensive open-dialogue approach in Western Lapland","volume":"3","author":"Aaltonen","year":"2011","journal-title":"Psychosis"},{"issue":"2","key":"2020070810443241600_CIT0049","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10597-017-0148-1","article-title":"Assessing the impact and effectiveness of hearing voices network self-help groups","volume":"54","author":"Longden","year":"2018","journal-title":"Community Ment Health J"},{"key":"2020070810443241600_CIT0050","article-title":"Drug-free psychiatric treatment \u2013 what do the patients think?","volume":"139","author":"Heskestad","year":"2019","journal-title":"Tidsskr Nor Laegeforen"},{"key":"2020070810443241600_CIT0051","doi-asserted-by":"crossref","DOI":"10.1007\/s00127-019-01819-2","article-title":"Experiences of taking neuroleptic medication and impacts on symptms, sense of self and agency: a systematic review and thematic synthesis of qualitative data","author":"Thompson","year":"2020","journal-title":"Soc Psychiatry Psychiatr Epidmiol"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/46\/4\/896\/33474970\/sbaa002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/46\/4\/896\/33474970\/sbaa002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T14:48:10Z","timestamp":1594219690000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/46\/4\/896\/5734534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,2,12]]},"published-print":{"date-parts":[[2020,7,8]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbaa002","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,2,12]]}}}